Diagnostic Microbiology and Infectious Disease

Article	Citations
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review	257
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)	77
The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review	69
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays	51
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals	50
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center	42
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection	40
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples	38
COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting	38
The risk factors associated with MERS-CoV patient fatality: A global survey	37
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units	36
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type	36
How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory	35
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection	34
The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.	31
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities	31
COVID-19 – 6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced	30
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies	28
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19	28
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study	28
Comparison of ceftazidime-avibactam and ceftolozane-tazobactam in vitro activities when tested against gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medica	27
Vaginal bacterial profiles of aerobic vaginitis: a case–control study	26
Changes in healthcare managing COVID and non–COVID-19 patients during the pandemic: striking the balance	25
Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples	25
Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (	25

Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa	25
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection	24
A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia	24
Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review	24
Heat inactivation decreases the qualitative real-time RT-PCR detection rates of clinical samples with high cycle threshold values in COVID-19	23
Detection of SARS-CoV-2 IgG antibodies in dried blood spots	23
Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectio	23
Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals	23
Advances in rapid diagnostics for bloodstream infections	23
Development of XRM-MacConkey agar selective medium for the isolation of Escherichia albertii	22
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitaliz	22
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018–2020)	21
Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire® FilmArray® pneumonia panel: a systematic review and meta-analysis	21
The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2	21
Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel	20
Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave	20
Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing	20
SARS-CoV-2 IgG antibody responses in New York City	19
Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing	19
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test	19
Prospective clinical validation of 3D printed nasopharyngeal swabs for diagnosis of COVID-19	18
Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018	18
Targeted next generation sequencing for elbow periprosthetic joint infection diagnosis	17
Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?	17
Time to positivity of acute and chronic periprosthetic joint infection cultures	17
Diagnostic accuracy of 5 different brands of dengue virus non-structural protein 1 (NS1) antigen rapid diagnostic tests (RDT) in Indonesia	17
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States	17
Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections	17
Respiratory bacterial pathogen spectrum among COVID-19 infected and non–COVID-19 virus infected pneumonia patients	17
A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL, and AmpC genes	17
Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection	16
In vitro activity of Ceftazidime–Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019	16
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii	16
Expanded sequential quadriplex real-time polymerase chain reaction (PCR) for identifying pneumococcal serotypes, penicillin susceptibility, and resistance markers	16
Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination	15
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case–control study	15
Systematic analysis, identification, and use of CRISPR/Cas13a–associated crRNAs for sensitive and specific detection of the lcrV gene of Yersinia pestis	15
Impact of FilmArray meningitis encephalitis panel on HSV testing and empiric acyclovir use in children beyond the neonatal period	15
Evaluation of dengue serological tests available in Puerto Rico for identification of prior dengue infection for prevaccination screening	15
Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia	15
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia	15
Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens	15
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report	15
Evaluation and comparison of automated and manual ELISA for diagnosis of chronic pulmonary aspergillosis (CPA) in Indonesia	14
Proposed nomenclature or classification changes for bacteria of medical importance: taxonomic update 5	14
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using	14
Streptococcus agalactiae infections and clinical relevance in adults, Thailand	14
Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables	14
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs	14
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014–2018): therapeutic options for multidrug-resis	14

In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017–2018	13
Evaluation of the Abbott PanbioTM COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians	13
Understanding false positives and the detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and BD MAX SARS-CoV-2 assays	13
Intact pap2 downstream of mcr-1 appears to be required for colistin resistance	13
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection	13
Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value	13
Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5– and IMP-7–type carbapenemases in a tertiary hospital	13
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG	13
A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease	13
Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature	12
Comparison of Lowenstein-Jensen medium and MGIT culture system for recovery of Mycobacterium tuberculosis from abscess samples	12
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals	12
In vitro activity of TNP-2092 against periprosthetic joint infection–associated staphylococci	12
Microbiological diagnosis of Acanthamoebic keratitis: experience from tertiary care center of North India	12
Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection	12
Staphylococcus aureus whole genome sequence–based susceptibility and resistance prediction using a clinically amenable workflow	12
Evaluation of diagnostic accuracy of loop-mediated isothermal amplification method (LAMP) compared with polymerase chain reaction (PCR) for Leptospira spp. in clinical samples: a systematic review and	12
Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients	12
The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening	12
Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019	12
Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020	12
Point-of-care tests for malaria: speeding up the diagnostics at the bedside and challenges in malaria cases detection	12
Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?	11
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test	11
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China	11
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay	11
Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing	11
Balamuthia mandrillaris encephalitis in a child: case report and literature review	11
A deletion in the N gene of SARS-CoV-2 may reduce test sensitivity for detection of SARS-CoV-2	11
Impact of the FilmArray meningitis/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection	11
Comparison of reverse-transcription qPCR and droplet digital PCR for the detection of SARS-CoV-2 in clinical specimens of hospitalized patients	11
Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients	10
Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays	10
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022)	10
In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae	10
Detection of herpes simplex and varicella-zoster virus from skin lesions: comparison of RT-PCR and isothermal amplification for rapid identification	10
Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients	10
Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients	10
Negative impact of the COVID-19 pandemic on the timely diagnosis of tick-borne infections	10
How to estimate time of infection with Toxoplasma gondii in pregnant women. Use of specific IgG and IgM kinetics by 7 techniques on 691 sera	10
Assay dependence of long-term kinetics of SARS-CoV-2 antibodies	10
Development and validation of a new scoring system for the early diagnosis of tuberculous meningitis in adults	10
Abbott ID now COVID-19 assay performance: a year in review	10
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories	10
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19	10
Staphylococcus pettenkoferi-positive Blood cultures in Hospitalized Patients in a Multi-site Tertiary Center	10
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection	10
Plasma cell-free metagenomic next generation sequencing in the clinical setting for the diagnosis of infectious diseases: a systematic review and meta-analysis	9
Comparison of SARS-CoV-2 molecular detection in nasopharyngeal swab, saliva, and gargle samples	9
Predictive ability of LRINEC score in the prediction of limb loss and mortality in diabetic foot infection	9
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019	9
Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases	9
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from Unit	9
Performance of a rapid antigen test for SARS-CoV-2 in Kenya	9
A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect	9
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus	9
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years	9
Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients	9
Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays	9
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary university hospital of Verona (northern It	9
Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform	9
Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC)	9
Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.	9
Catheter-related bloodstream infection due to Tsukamurella pulmonis identified by MALDI-TOF spectrometry, 16S rRNA gene sequencing, and secA1 gene sequencing in an immunocompromised child: a case repo	9
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States	9
A deletion in the N gene may cause diagnostic escape in SARS-CoV-2 samples	9
SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil	9
A quantitative enzyme-linked immunoassay (ELISA) to approximate complement-fixing antibody titers in serum from patients with coccidioidomycosis	8
Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples	8
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012–2018)	8
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD stud	8
Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis	8
Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia	8
Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity	8
In vitro activity of ceftaroline and ceftobiprole against clinical isolates of Gram-positive bacteria from infective endocarditis: are these drugs potential options for the initial management of this	8
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays	8
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant	8
Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative/Confirmatory assays	8
Rapid microbial identification and phenotypic antimicrobial susceptibility testing directly from positive blood cultures: a new platform compared to routine laboratory methods	8
A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy	8

In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014–2017 and 2018	8
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates	8
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales	8
Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods	8
Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study	8
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response	8
False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease	8
Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study	8
Intestinal carriage of colistin resistant Enterobacteriaceae in hospitalized patients from an Indian center	7
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)	7
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011–2018	7
Pooling samples: a testing option for SARS-CoV-2 during a supply shortage	7
The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis	7
Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma	7
Rapid qualitative antibiotic resistance characterization using VITEK MS	7
Detection of potential enteric pathogens in children with severe acute gastroenteritis using the filmarray: Results from a three - years hospital-based survey in Northern Italy	7
Development and evaluation of a multiplex conventional reverse-transcription polymerase chain reaction assay for detection of common viral pathogens causing acute gastroenteritis	7
Risk factors for focal involvement in brucellosis	7
Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs	7
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis	7
Clinical impact of implementation of rapid diagnostic testing of blood cultures with Staphylococcus aureus on patient outcomes	7
Synergistic antibacterial effects of analgesics and antibiotics against Staphylococcus aureus	7
Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-2	7
Evaluation of automated antigen detection test for detection of SARS-CoV-2	7
Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil	7
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19	7
The impact of rapid diagnostic testing, surveillance software, and clinical pharmacist staffing at a large community hospital in the management of Gram-negative bloodstream infections	7
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales	7
Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2	7
Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence	7
Emergence and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient	7
Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department	7
A case series of patients with Gemella endocarditis	7
Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease	7
Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India	7
Genotypic characterization of ‘inferred’ rifampin mutations in GenoType MTBDRplus assay and its association with phenotypic susceptibility testing of Mycobacterium tuberculosis.	6
Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system	6
Performance of ceftriaxone susceptibility testing on the Accelerate Pheno® system of ESBL-producing isolates	6
Development of a species-specific real-time PCR test for Chlamydia psittaci and its employment in the investigation of zoonotic transmission from racing pigeons in Denmark	6
Screening methods for intestinal carriage of multidrug-resistant Enterobacterales: interest of enrichment broth	6
The challenge of COVID-19 for a Clinical Microbiology Department	6
Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow	6
Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance	6
Extractionless nucleic acid detection: a high capacity solution to COVID-19 testing	6
Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification	6
The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation	6
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2	6
Rapid identification of the vanA/vanB resistance determinant in Enterococcus sp. from blood cultures using the Cepheid Xpert vanA/vanB cartridge system	6
In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobip	6
Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 2017	6
Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort	6
IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination	6
SARS-CoV-2 diagnostics: Some reflections on current assays	6
Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2	6
Polymyxin B broth disk elution: a feasible and accurate methodology to determine polymyxin B susceptibility in Enterobacterales	6
Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France	6
Surgical infective endocarditis and concurrent splenic abscess requiring splenectomy: a case series and review of the literature	6
Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies	5
Aggregation of data from 4 clinical studies demonstrating efficacy of single-dose doxycycline postexposure for prevention of the spirochetal infections: Lyme disease, syphilis, and tick-borne relapsin	5
SARS-CoV-2 screening in patients in need of urgent inpatient treatment in the Emergency Department (ED) by digitally integrated point-of-care PCR: a clinical cohort study	5
Prospective multicenter comparison of urine culture with PCR on dried blood spots using 2 different extraction and PCR methods in neonates suspected for congenital cytomegalovirus infection	5
Enterococcus faecalis in blood cultures—a prospective study on the role of persistent bacteremia	5
Impact of freeze/thaw cycles and single freezing at −80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwabTM system	5
Matrix-assisted laser desorption ionization-time of flight mass spectrometry can be used to identify Helicobacter cinaedi	5
Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada – SMART 2018-2019	5
Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains	5
Rapid detection of carbapenemase-producing Pseudomonas spp. using the NitroSpeed-Carba NP test	5
Analytical and clinical evaluation of new automated chemiluminescent immunoassays for the detection of IgG and IgM anti-Bartonella henselae antibodies	5
Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 – 2020	5
Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre-Sars-CoV-2 environment	5
Genotypic distribution of Staphylococcus aureus colonizing children and adolescents in daycare centers, an outpatient clinic, and hospitals in a major Brazilian urban setting	5
The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center	5
Rapid and sensitive detection of SARS-CoV-2 variants in nasopharyngeal swabs and wastewaters	5
Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens	5
Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay	5
Molecular detection of Mycobacterium tuberculosis in blood stained sputum samples using GeneXpert PCR assay	5
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus	5
Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology	5
Fast and reliable detection of carbapenemase genes in various Gram negatives using a new commercially available fluorescence-based real-time polymerase chain reaction platform	5
Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis	5
Coinfections among hospitalized patients with covid-19 in the first pandemic wave	5
Rapid detection of Enterobacterales that produce carbapenemases	5
Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia	5
Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients	5
Whole-genome analysis of SARS-CoV-2 samples indicate no tissue specific genetic adaptation of the virus in COVID-19 patients’ upper and lower respiratory tract	5
Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection	5
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes	5
Epidemiology and regional variation of nonsusceptible and multidrug-resistant Pseudomonas aeruginosa isolates from intensive versus non-intensive care units across multiple centers in the United State	5
Performance of PhenoMatrix for the detection of Group B Streptococcus from recto-vaginal swabs	5
Dynamics of nosocomial parainfluenza virus type 3 and influenza virus infections at a large German University Hospital between 2012 and 2019	5
Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?	4
Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam	4
Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels	4
False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity	4
Relevance of Dermabacter hominis isolated from clinical samples, 2012–2016: a retrospective case series	4